OSR HEALTH, INC. Increase (Decrease) in Accrued Liabilities
OSR HEALTH, INC. (OSRH) reported Increase (Decrease) in Accrued Liabilities of $56.37 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-14
- OSR HEALTH, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$32.02K, a 149.54% decline year-over-year.
- OSR HEALTH, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was $88.39K, a 6.88% decline year-over-year.
- OSR HEALTH, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $189.93K.
- OSR HEALTH, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $127.17K.
- OSR HEALTH, INC. increase (decrease) in accrued liabilities for fiscal 2025 was $476.64K, a 13952.03% increase from fiscal 2024.
- OSR HEALTH, INC. increase (decrease) in accrued liabilities for fiscal 2024 was $3.39K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$32.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $56.37K 10-Q · filed 2026-08-14 | $246.30K derived: sum of 3 quarters · filed 2026-08-14 | $373.47K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $88.39K 10-Q · filed 2026-05-13 | $278.32K derived: sum of 2 quarters · filed 2026-05-13 | $405.48K derived: sum of 3 quarters · filed 2026-05-13 | $470.11K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $189.93K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $317.09K derived: sum of 2 quarters · filed 2026-03-31 | $381.72K derived: sum of 3 quarters · filed 2026-08-14 | $476.64K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $127.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $191.80K derived: sum of 2 quarters · filed 2026-08-14 | $286.72K 10-Q · filed 2025-11-12 | $266.67K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $64.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $159.55K 10-Q · filed 2026-08-14 | $139.50K derived: sum of 3 quarters · filed 2026-08-14 | $105.93K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $94.92K 10-Q · filed 2026-05-13 | $94.92K 10-Q · filed 2025-05-20 | $74.87K derived: sum of 2 quarters · filed 2026-05-13 | $41.30K derived: sum of 3 quarters · filed 2026-05-13 | $93.51K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$20.05K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$53.62K derived: sum of 2 quarters · filed 2026-03-31 | -$1.41K derived: sum of 3 quarters · filed 2026-03-31 | $3.39K 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$33.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $18.64K derived: sum of 2 quarters · filed 2025-11-12 | $23.45K 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $52.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $57.01K 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | $4.80K 10-Q · filed 2025-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |